Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 36

1.

Sex differences in elbow and wrist joint loading during the cartwheel and round off with different hand positions performed by young gymnasts.

Farana R, Strutzenberger G, Exell T, Skypala J, Wiltshire H, Irwin G.

J Sports Sci. 2019 Jul;37(13):1449-1456. doi: 10.1080/02640414.2019.1565110. Epub 2019 Jan 11.

PMID:
30633642
2.

Analyzing the effect of an arch support functional insole on walking and jogging in young, healthy females.

Zhao X, Wang M, Fekete G, Baker JS, Wiltshire H, Gu Y.

Technol Health Care. 2018 Nov 9. doi: 10.3233/THC-181373. [Epub ahead of print]

PMID:
30452428
3.

Psychological consequences of childhood obesity: psychiatric comorbidity and prevention.

Rankin J, Matthews L, Cobley S, Han A, Sanders R, Wiltshire HD, Baker JS.

Adolesc Health Med Ther. 2016 Nov 14;7:125-146. eCollection 2016. Review.

4.
5.

Interrelationships between measured running intensities and agility performance in subelite rugby union players.

Jarvis S, Sullivan LO, Davies B, Wiltshire H, Baker JS.

Res Sports Med. 2009;17(4):217-30. doi: 10.1080/15438620903323892.

PMID:
19967601
6.

Reliability of the Ekblom soccer-specific endurance test.

Williams MD, Wiltshire HD, Lorenzen C, Wilson CJ, Meehan DL, Cicioni Kolsky DJ.

J Strength Cond Res. 2009 Aug;23(5):1378-82. doi: 10.1519/JSC.0b013e31819f1e6c.

PMID:
19593222
7.

Results of a phase I/II British Society of Bone Marrow Transplantation study on PCR-based pre-emptive therapy with valganciclovir or ganciclovir for active CMV infection following alemtuzumab-based reduced intensity allogeneic stem cell transplantation.

Lim ZY, Cook G, Johnson PR, Parker A, Zuckerman M, Marks D, Wiltshire H, Mufti GJ, Pagliuca A.

Leuk Res. 2009 Feb;33(2):244-9. doi: 10.1016/j.leukres.2008.07.016. Epub 2008 Sep 20.

PMID:
18805583
8.

Oseltamivir distributes to influenza virus replication sites in the middle ear and sinuses.

Kurowski M, Oo C, Wiltshire H, Barrett J.

Clin Drug Investig. 2004;24(1):49-53. No abstract available.

PMID:
17516690
9.

Pharmacodynamics of oral ganciclovir and valganciclovir in solid organ transplant recipients.

Wiltshire H, Paya CV, Pescovitz MD, Humar A, Dominguez E, Washburn K, Blumberg E, Alexander B, Freeman R, Heaton N, Zuideveld KP; Valganciclovir Solid Organ Transplant Study Group.

Transplantation. 2005 Jun 15;79(11):1477-83.

PMID:
15940035
10.

Pharmacokinetic profile of ganciclovir after its oral administration and from its prodrug, valganciclovir, in solid organ transplant recipients.

Wiltshire H, Hirankarn S, Farrell C, Paya C, Pescovitz MD, Humar A, Dominguez E, Washburn K, Blumberg E, Alexander B, Freeman R, Heaton N; Valganciclovir Solid Organ Transplant Study Group.

Clin Pharmacokinet. 2005;44(5):495-507.

PMID:
15871635
11.

Modulation of oral squamous cell carcinoma incidence in rats via diet and a novel calcium channel antagonist.

Lenz B, Crameri FM, Eichler DA, Schl├Ąppi B, Wiltshire HR, Wood J, Seymour RA.

Toxicol Pathol. 2005;33(3):356-64.

PMID:
15805073
12.

Factors responsible for the variability of saquinavir absorption: studies using an instrumented dog model.

Tam-Zaman N, Tam YK, Tawfik S, Wiltshire H.

Pharm Res. 2004 Mar;21(3):436-42.

PMID:
15070093
13.

Oral valganciclovir in children: single dose pharmacokinetics in a six-year-old girl.

Burri M, Wiltshire H, Kahlert C, Wouters G, Rudin C.

Pediatr Infect Dis J. 2004 Mar;23(3):263-6.

PMID:
15014306
14.

Assessing safety and efficacy of directed P-glycoprotein inhibition to improve the pharmacokinetic properties of saquinavir coadministered with ritonavir.

Huisman MT, Smit JW, Wiltshire HR, Beijnen JH, Schinkel AH.

J Pharmacol Exp Ther. 2003 Feb;304(2):596-602.

PMID:
12538811
15.

Multidrug resistance protein 2 (MRP2) transports HIV protease inhibitors, and transport can be enhanced by other drugs.

Huisman MT, Smit JW, Crommentuyn KM, Zelcer N, Wiltshire HR, Beijnen JH, Schinkel AH.

AIDS. 2002 Nov 22;16(17):2295-301.

PMID:
12441801
16.

CYP3A4-mediated hepatic metabolism of the HIV-1 protease inhibitor saquinavir in vitro.

Eagling VA, Wiltshire H, Whitcombe IW, Back DJ.

Xenobiotica. 2002 Jan;32(1):1-17.

PMID:
11824416
17.

The anti-influenza drug oseltamivir exhibits low potential to induce pharmacokinetic drug interactions via renal secretion-correlation of in vivo and in vitro studies.

Hill G, Cihlar T, Oo C, Ho ES, Prior K, Wiltshire H, Barrett J, Liu B, Ward P.

Drug Metab Dispos. 2002 Jan;30(1):13-9.

PMID:
11744606
18.

P-glycoprotein limits oral availability, brain, and fetal penetration of saquinavir even with high doses of ritonavir.

Huisman MT, Smit JW, Wiltshire HR, Hoetelmans RM, Beijnen JH, Schinkel AH.

Mol Pharmacol. 2001 Apr;59(4):806-13.

PMID:
11259625
19.

Elevated alpha-1-acid glycoprotein reduces the volume of distribution and systemic clearance of saquinavir.

Holladay JW, Dewey MJ, Michniak BB, Wiltshire H, Halberg DL, Weigl P, Liang Z, Halifax K, Lindup WE, Back DJ.

Drug Metab Dispos. 2001 Mar;29(3):299-303.

PMID:
11181499
20.
21.

The disposition of saquinavir in normal and P-glycoprotein deficient mice, rats, and in cultured cells.

Washington CB, Wiltshire HR, Man M, Moy T, Harris SR, Worth E, Weigl P, Liang Z, Hall D, Marriott L, Blaschke TF.

Drug Metab Dispos. 2000 Sep;28(9):1058-62.

PMID:
10950849
22.

Chromatographic and immunochemical approaches to the analysis of the HIV protease inhibitor saquinavir in plasma.

Wiltshire HR, Wiltshire BG, Clarke AF, Worth E, Prior KJ, Tjia JF.

Anal Biochem. 2000 May 15;281(1):105-14.

PMID:
10847617
23.

Absence or pharmacological blocking of placental P-glycoprotein profoundly increases fetal drug exposure.

Smit JW, Huisman MT, van Tellingen O, Wiltshire HR, Schinkel AH.

J Clin Invest. 1999 Nov;104(10):1441-7.

24.

Clinical pharmacokinetics of mibefradil.

Welker HA, Wiltshire H, Bullingham R.

Clin Pharmacokinet. 1998 Dec;35(6):405-23. Review.

PMID:
9884814
25.

thy/liv-SCID-hu mice: a system for investigating the in vivo effects of multidrug therapy on plasma viremia and human immunodeficiency virus replication in lymphoid tissues.

Pettoello-Mantovani M, Kollmann TR, Katopodis NF, Raker C, Kim A, Yurasov S, Wiltshire H, Goldstein H.

J Infect Dis. 1998 Feb;177(2):337-46.

PMID:
9466519
26.
27.
28.

Metabolism of the calcium antagonist, mibefradil (POSICOR, Ro 40-5967). Part II. Metabolism in hepatic microsomes from rat, marmoset, cynomolgus monkey, rabbit and man.

Wiltshire HR, Sutton BM, Heeps G, Betty AM, Angus DW, Madigan MJ, Sharp SR.

Xenobiotica. 1997 Jun;27(6):539-56.

PMID:
9211655
30.

The Drug Metabolism Discussion Group 1991.

Franklin RA, Vose CW, Wiltshire H.

Xenobiotica. 1992 Jul;22(7):733-4. No abstract available.

PMID:
1455895
31.

Displacement of the superior sagittal sinus associated with a brain tumor.

Zilkha A, Wiltshire HE, Irwin GA, Borofsky LG.

Childs Brain. 1977;3(6):352-8.

PMID:
590046
32.
33.

Studies of enzyme-mediated reactions. II. Stereochemistry of the elimination of ammonia from L-tyrosine catalysed by the enzyme from maize.

Strange PG, Stauton J, Wiltshire HR, Battersby AR, Hanson KR, Havir EA.

J Chem Soc Perkin 1. 1972;18:2364-72. No abstract available.

PMID:
4674458
34.

The variation of cycle times with repetition for manual tasks.

Wiltshire HC.

Ergonomics. 1967 May;10(3):331-47. No abstract available.

PMID:
6077521
35.

The letter series as a projective technique.

WILTSHIRE HM.

J Clin Psychol. 1951 Apr;7(2):167-70. No abstract available.

PMID:
14824310
36.

Informational Content of Children in the First Four Grades.

Wiltshire H.

Psychol Clin. 1933 Sep-Nov;22(3):198-207. No abstract available.

Supplemental Content

Loading ...
Support Center